Bafna Pharmaceuticals Ltd. Company Profile:Products,Promoters and Clients

Bafna Pharmaceuticals Ltd Company Description:

Established in 1981, Bafna Pharmaceuticals Ltd is a manufacturer of finished pharmaceutical formulations.

Investing has built huge wealth for several HNI investors. Learn investing FREE OF CHARGE at Sovrenn Education  

Q1.What are the Products and Service offerings of Bafna Pharmaceuticals Ltd ?

Product Profile: Bafna Pharmaceuticals produces over 336 licensed pharmaceutical formulations. The company has globally registered 78 products, including Afenac-p Tab, Afenac-th Tab, and various solid and liquid oral dosage forms of Betalactam, Non-Betalactam, and Cephalosporin products.

Q2.Who are the Promoters of Bafna Pharmaceuticals Ltd ?

Mr. Vinayak Dinesh Dendukuri Mr. Vinayak is the Co-founder & Director of NOVICK Biosciences. Under his guidance and leadership, NOVICK has established a system that delivers high-quality pharmaceutical product development services, assuring sound fiscal operations. 

Mr. Vinayak is also a Director of Brane Enterprises, a company emphasizing natural language (no coding) and machine learning. Prior to this role, Mr. Vinayak was Drug Safety Scientist at Quintiles, leading Phase II and Phase III clinical trials across the globe for major Pharmaceutical companies. Mr. Vinayak also served as a Scientist in several positions at Sanofi Pasteur and GlaxoSmithKline, USA. 

He completed his Bachelor's in Biotechnology from Rochester Institute of Technology, USA, and his Master's in Microbiology, Immunology, and Biochemistry from the University of Rochester, USA.

Finding multibagger stocks is important for building wealth. Discover potential multibaggers at Sovrenn Discovery

Mr. Upendar Mekala Reddy Vice President – iLabs Capital
Upendar is an Investment Manager at iLabs Group. He holds MBA Degree with specialisation in finance from Indian Institute of Management Kozhikode (IIMK), Bachelor of Technology in Computer Science Engineering from JNTU - Hyderabad and FRM Certification from Global Association of Risk Professionals (GARP) Upendar has over 15 years of experience spanning project and structured finance, fund raising, Mergers and Acquisitions and Investment Banking. 

He has executed transactions across sectors including Power (Renewable & Non-renewable), Pharmaceuticals, Roads, Manufacturing, Cement, Real estate, Ports, etc Prior to iLabs Group, Upendar was working as Vice President with Edelweiss Financial Services handling the wholesale and structured lending business. 

He also worked as Assistant Vice President with IL&FS Financial Services and Senior Manager with L&T Infrastructure Finance in the Project Finance Team.

Also Read: Alufluoride Company Profile: Products, Promoters and Clients

Q3.Who are the Clients of Bafna Pharmaceuticals Ltd ?

The clients of the company were not publicly mentioned.Please find the following detais about Revenue,Geographical Split and Export Markets:

Revenue Breakdown - FY23:

• Sale of Products: ~96%
• Analytical Income: ~1%
• Gain on Foreign Exchange Difference: ~2%
• Freight Income: ~1%

Geographical Revenue Split - FY23:

• Export: ~77%
• Domestic: ~23%

Export Markets: Bafna Pharmaceuticals exports its products to several countries, including the UK, Australia, Ukraine, Sri Lanka, Philippines, Nigeria, Ethiopia, Tanzania, Nepal, Kenya, Sudan, Myanmar, Uganda, Azerbaijan, Democratic Republic of Congo, Guatemala, Mauritius, EU - GMP, Honduras, Madagascar, Peru, and Zambia.

Also Read: PG Electroplast Limited (PGEL) Company Profile: Products, Promoters and Clients

(By Medhansh Bairaria)